Literature DB >> 8794344

Adenovirus-mediated gene transfer to ciliated airway epithelia requires prolonged incubation time.

J Zabner1, B G Zeiher, E Friedman, M J Welsh.   

Abstract

The efficiency of adenovirus-mediated gene transfer to airway epithelia will be an important factor in determining whether recombinant adenoviruses can be developed as vectors for transferring cystic fibrosis transmembrane conductance regulator (CFTR) cDNA to patients with cystic fibrosis. Current understanding of the biology of CF lung disease suggests that vectors should express transgene in mature, ciliated airway epithelia. We evaluated the efficiency of adenovirus-mediated gene transfer to primary cultures of normal and CF human airway epithelia. Our studies showed that the airway cells developed from an undifferentiated epithelium with markers characteristic of basal cells and a surface covered by short microvilli 3 days after seeding to a mature epithelium whose apical surface was covered with cilia by 10 to 14 days. The ability of adenovirus vectors to express a reporter gene and to correct defective cyclic AMP-stimulated Cl- transport in CF epithelia was correlated inversely with the state of differentiation. However, the inefficiency of adenovirus-mediated gene transfer could be partially corrected when the contact time between vector and epithelium was prolonged. After prolonged contact, we observed complete correction of the CF Cl- transport defect in differentiated CF airway epithelia in culture and of the Cl- transport defect in the nasal epithelia of mice homozygous for the deltaF508 mutation. The fact that gene transfer to airway epithelia required prolonged incubation with vector contrasts with the rapid infection observed in cell models such as 293 and HeLa cells, which are commonly used to study adenovirus infection. Gene transfer observed after prolonged incubation may result from mechanisms different from those that mediate infection of 293 cells. These observations suggest that interventions that either increase the contact time or alter the epithelium or the vector may be required to facilitate gene transfer to ciliated respiratory epithelia.

Entities:  

Mesh:

Year:  1996        PMID: 8794344      PMCID: PMC190750     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Adenovirus-mediated gene transfer for cystic fibrosis: Part A. Safety of dose and repeat administration in the nasal epithelium. Part B. Clinical efficacy in the maxillary sinus.

Authors:  M J Welsh; J Zabner; S M Graham; A E Smith; R Moscicki; S Wadsworth
Journal:  Hum Gene Ther       Date:  1995-02       Impact factor: 5.695

2.  Expression of alpha v beta 5 integrin is necessary for efficient adenovirus-mediated gene transfer in the human airway.

Authors:  M J Goldman; J M Wilson
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

3.  Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector.

Authors:  J G Hay; N G McElvaney; J Herena; R G Crystal
Journal:  Hum Gene Ther       Date:  1995-11       Impact factor: 5.695

4.  Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain.

Authors:  S C Stevenson; M Rollence; B White; L Weaver; A McClelland
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

Review 5.  Culture and transformation of human airway epithelial cells.

Authors:  D C Gruenert; W E Finkbeiner; J H Widdicombe
Journal:  Am J Physiol       Date:  1995-03

6.  Humoral and cellular immune responses of nonhuman primates to long-term repeated lung exposure to Ad2/CFTR-2.

Authors:  J M Kaplan; J A St George; S E Pennington; L D Keyes; R P Johnson; S C Wadsworth; A E Smith
Journal:  Gene Ther       Date:  1996-02       Impact factor: 5.250

7.  A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis.

Authors:  M R Knowles; K W Hohneker; Z Zhou; J C Olsen; T L Noah; P C Hu; M W Leigh; J F Engelhardt; L J Edwards; K R Jones
Journal:  N Engl J Med       Date:  1995-09-28       Impact factor: 91.245

8.  Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung.

Authors:  S Yei; N Mittereder; K Tang; C O'Sullivan; B C Trapnell
Journal:  Gene Ther       Date:  1994-05       Impact factor: 5.250

9.  Differential sensitivity of thoracic malignant tumors to adenovirus-mediated drug sensitization gene therapy.

Authors:  W R Smythe; H C Hwang; A A Elshami; K M Amin; S M Albelda; L R Kaiser
Journal:  J Thorac Cardiovasc Surg       Date:  1995-04       Impact factor: 5.209

10.  A mouse model for the delta F508 allele of cystic fibrosis.

Authors:  B G Zeiher; E Eichwald; J Zabner; J J Smith; A P Puga; P B McCray; M R Capecchi; M J Welsh; K R Thomas
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

View more
  46 in total

1.  Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors.

Authors:  N Miyazawa; P L Leopold; N R Hackett; B Ferris; S Worgall; E Falck-Pedersen; R G Crystal
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  The osmolyte xylitol reduces the salt concentration of airway surface liquid and may enhance bacterial killing.

Authors:  J Zabner; M P Seiler; J L Launspach; P H Karp; W R Kearney; D C Look; J J Smith; M J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

3.  Adenoviral transduction of enterocytes and M-cells using in vitro models based on Caco-2 cells: the coxsackievirus and adenovirus receptor (CAR) mediates both apical and basolateral transduction.

Authors:  Filippos Kesisoglou; Phyllissa Schmiedlin-Ren; David Fleisher; Ellen M Zimmermann
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

4.  The air-liquid interface and use of primary cell cultures are important to recapitulate the transcriptional profile of in vivo airway epithelia.

Authors:  Alejandro A Pezzulo; Timothy D Starner; Todd E Scheetz; Geri L Traver; Ann E Tilley; Ben-Gary Harvey; Ronald G Crystal; Paul B McCray; Joseph Zabner
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-10-22       Impact factor: 5.464

5.  Incorporation of adeno-associated virus in a calcium phosphate coprecipitate improves gene transfer to airway epithelia in vitro and in vivo.

Authors:  R W Walters; D Duan; J F Engelhardt; M J Welsh
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Bidirectional virus secretion and nonciliated cell tropism following Andes virus infection of primary airway epithelial cell cultures.

Authors:  Regina K Rowe; Andrew Pekosz
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

7.  Adenoviral gene transfer of endothelial nitric-oxide synthase (eNOS) partially restores normal pulmonary arterial pressure in eNOS-deficient mice.

Authors:  Hunter C Champion; Trinity J Bivalacqua; Stanley S Greenberg; Thomas D Giles; Albert L Hyman; Philip J Kadowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-17       Impact factor: 11.205

8.  Bronchoalveolar fluid is not a major hindrance to virus-mediated gene therapy in cystic fibrosis.

Authors:  C P Rooney; G M Denning; B P Davis; D M Flaherty; J A Chiorini; J Zabner
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed.

Authors:  Vincent H J Leonard; Patrick L Sinn; Gregory Hodge; Tanner Miest; Patricia Devaux; Numan Oezguen; Werner Braun; Paul B McCray; Michael B McChesney; Roberto Cattaneo
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

10.  Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer.

Authors:  R J Pickles; D McCarty; H Matsui; P J Hart; S H Randell; R C Boucher
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.